Abstract:Ten middle-aged males participated in a crossover study to determine the cholesterolemic effect of high amounts of stearic acid in a natural diet. They consumed a 20-d stabilization diet followed by two 40-d intervention diets containing either 1.5% of energy as stearic (18:0) acid and 7.3% of energy as palmitic (16:0) acid (low stearate: LS) or 2.4% of energy as 16:0 and 7.3% of energy as 18:0 (high stearate: HS). The experimental diets also contained approximately 10% of energy each as saturated and monounsa… Show more
“…This is in accordance with results published earlier by others (Tholstrup et al, 1994;Yu et al, 1995;Dougherty et al, 1995;Aro et al, 1997), who also found that when stearic acid is exchanged for C12±14 saturates, a moderate decrease in HDL-C was observed.…”
Objective: The aim of this present project was to evaluate a more satisfactory effect on plasma lipoprotein pro®le of spreads based on dairy fat. Design: This study was designed as a randomised cross-over experiment with a three-week treatment separated by a three-week wash-out period. Sixty ®ve grams of the fat content of the habitual diets was replaced by either butteragrapeseed oil (90 : 10) (BG); butter oil and low erucic rapeseed oil (65 : 35) (BR) or butter blended in a 1 : 1 ratio with a interesteri®ed mixture of rapeseed oil and fully hydrogenated rapeseed oil (70 : 30) (BS). Subjects: Thirteen healthy free-living young men (age 21±26 y) ful®lled the study. Interventions: At the beginning and end of each diet period two venous blood samples were collected. Triacylglycerol and cholesterol concentrations in total plasma and VLDL, LDL, IDL and HDL fractions were measured, as were apo A-1 and apo B concentrations. Fatty acid composition of plasma phospholipids, plasma cholesterol ester and platelets was also determined. Results: Signi®cantly (P`0.05) lower total and LDL-cholesterol concentrations were observed after the BR and BS period, compared to BG. The effect of BR and BS did not differ. BG and BR resulted in equal concentrations of HDL-C, but signi®cantly higher than BS. Consequently, a signi®cantly lower LDL-CaHDL-C ratio was seen after the BR treatment compared to BG and BS. Apo A-1 concentrations were not signi®cantly different, but Apo B was signi®cantly increased after BG. Conclusions: Partially replacing milk fat with rapeseed oil seems to yield a more healthy spread. Stearic acid had a HDL-C lowering effect compared to milk fat, but did not affect LDL-C signi®cantly. The addition of stearic acid did not improve the plasma lipoprotein pro®le for young men with low cholesterol levels.
“…This is in accordance with results published earlier by others (Tholstrup et al, 1994;Yu et al, 1995;Dougherty et al, 1995;Aro et al, 1997), who also found that when stearic acid is exchanged for C12±14 saturates, a moderate decrease in HDL-C was observed.…”
Objective: The aim of this present project was to evaluate a more satisfactory effect on plasma lipoprotein pro®le of spreads based on dairy fat. Design: This study was designed as a randomised cross-over experiment with a three-week treatment separated by a three-week wash-out period. Sixty ®ve grams of the fat content of the habitual diets was replaced by either butteragrapeseed oil (90 : 10) (BG); butter oil and low erucic rapeseed oil (65 : 35) (BR) or butter blended in a 1 : 1 ratio with a interesteri®ed mixture of rapeseed oil and fully hydrogenated rapeseed oil (70 : 30) (BS). Subjects: Thirteen healthy free-living young men (age 21±26 y) ful®lled the study. Interventions: At the beginning and end of each diet period two venous blood samples were collected. Triacylglycerol and cholesterol concentrations in total plasma and VLDL, LDL, IDL and HDL fractions were measured, as were apo A-1 and apo B concentrations. Fatty acid composition of plasma phospholipids, plasma cholesterol ester and platelets was also determined. Results: Signi®cantly (P`0.05) lower total and LDL-cholesterol concentrations were observed after the BR and BS period, compared to BG. The effect of BR and BS did not differ. BG and BR resulted in equal concentrations of HDL-C, but signi®cantly higher than BS. Consequently, a signi®cantly lower LDL-CaHDL-C ratio was seen after the BR treatment compared to BG and BS. Apo A-1 concentrations were not signi®cantly different, but Apo B was signi®cantly increased after BG. Conclusions: Partially replacing milk fat with rapeseed oil seems to yield a more healthy spread. Stearic acid had a HDL-C lowering effect compared to milk fat, but did not affect LDL-C signi®cantly. The addition of stearic acid did not improve the plasma lipoprotein pro®le for young men with low cholesterol levels.
“…The proportion of fatty acids (free, soaps or derived from acylglycerols) of the total lipids has rarely been reported, but the fatty acid concentration in feces has been between 0.2 and 6 g/day (Bonanome and Grundy, 1988;Denke et al, 1993), typically 2-4 g/day (see e.g. Denke and Grundy, 1991;Dougherty et al, 1995;Snook et al, 1999). In the present study, crude fat excretion was at the expected level.…”
Section: Fecal Lipid Content and Compositionsupporting
confidence: 43%
“…The absorption of stearic acid from natural fats and oil is currently estimated to lie between 86 and 98% (Denke and Grundy, 1991;Dougherty et al, 1995;Baer et al, 2003). This is in conflict with the reported 63% absorption of stearic acid from Salatrim .…”
Objective: Absorption of stearic acid from natural oils has been shown to be efficient, but it is claimed to be lower from shortand long-acyl-chain triacylyglycerol molecules (Salatrim). The aim was to measure the apparent absorption of stearic acid from Salatrim fat in an acute test meal. Design: Double-blind crossover study. Subjects: Ten healthy male volunteers, of whom eight completed the study. Methods: The subjects were studied on two occasions after consumption of a single high-fat meal either without (control) or with 30 g of Salatrim. Fecal samples were collected for 96 h after the meal and the fat was extracted for analysis of the content and composition of free and esterified long-chain fatty acids. Results: Baseline fecal fat was 5.672.6 g/day increasing to 10.474.9 g/day after addition of Salatrim (P ¼ 0.001). During the whole collection period, the baseline fecal free and esterified fatty acids were 2.672.3 and 0.870.7 g, respectively. After Salatrim meal the corresponding figures increased to 5.973.6 g (P ¼ 0.001) and 1.5 (71.2) g (P ¼ 0.003), respectively. The total fecal stearic acid after control meal was 0.9770.9 g. Consumption of Salatrim with 16.770.5 g of stearic acid increased the content to 3.1271.6 g (Po0.001), with apparent absorption of 87%. Conclusions: The apparent absorption of stearic acid does not differ from its absorption from natural fats. The status of Salatrim as a low-energy fat substitute needs to be re-evaluated. Sponsorship: University of Turku.
“…These results are consistent with data from Bonanome and Grundy (1988), Tholstrup et al (1994) and Kelly et al (2001), who demonstrated this decrease with greater calculated total dietary stearic acid intakes of 46 g, 58 g and 19.4 g per day, respectively. Tholstrup et al (1994), Dougherty et al (1995) and Kelly et al (2001) have previously reported a significant decrease in HDL cholesterol concentrations on high stearic acid diets (58, 23.6 and 19.4 g per day, respectively) compared with baseline.…”
Section: Discussionmentioning
confidence: 94%
“…Subsequently, it was found that stearic acid was neutral in relation to plasma cholesterol changes (Hegsted et al, 1965;Keys et al, 1965). There are now a number of dietary studies which support the unique cholesterol-neutral properties of stearic acid (Kris-Etherton and Mustad, 1994;Tholstrup et al, 1994;Bonanome & Grundy, 1988), however the mechanisms behind this effect are not yet clear (Bonanome & Grundy, 1989;Kris-Etherton et al, 1993;Emken, 1994;Tholstrup et al, 1994;Dougherty et al, 1995;Rhee et al, 1997;Salter et al, 1998).…”
Objective: To determine whether healthy males who consumed increased amounts of dietary stearic acid compared with increased dietary palmitic acid through the consumption of commercially available foods, exhibited any changes in plasma lipids, platelet aggregation or platelet activation status. Design: A randomised cross-over dietary intervention. Subjects and interventions: Nine free-living healthy males consumed two experimental diets (stearic acid enriched, diet S, and palmitic acid enriched, diet P) for 3 weeks in a randomised cross-over design separated by a 3 week washout phase. The diets consisted of $ 30% of energy as fat (30% of which was derived from the treatment diets) providing $ 13 g=day as stearic acid and 17 g=day as palmitic acid on diet S and $ 7 g=day as stearic acid and 22 g=day as palmitic acid on diet P. The dietary ratio of stearic to palmitic acids was 0.76 on diet S compared with 0.31 on diet P. Blood samples were collected on days 0 and 21 of each dietary period. Results: LDL cholesterol levels and platelet aggregation response to the agonist ADP were significantly decreased (P < 0.025) in subjects on diet S compared with day 0. Apart from that, there were no significant changes in plasma lipids, platelet aggregation, mean platelet volume and platelet reactivity between diets. There were no significant changes in stearic or palmitic acid levels in plasma phospholipid or triacylglycerol. There was a significant difference in palmitic acid levels in platelet phospholipids between the two diets. Conclusions: Use of commonly available foods led to a 27% increase in stearic acid (diet S) and a 19% increase in palmitic acid (diet P), on diets S and P respectively, and no significant differences between the two diets in plasma lipoprotein concentrations, platelet aggregation or platelet activation status.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.